Cargando…
Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway
Chronic liver disease(CLD) is a slow-developing and long-term disease that can cause serious damage to the liver. Thus far, it has been associated with viral hepatitis, non-alcoholic fatty liver disease(NAFLD), alcoholic liver disease(ALD), hepatic fibrosis(HF), liver cirrhosis (LC), and liver cance...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586778/ https://www.ncbi.nlm.nih.gov/pubmed/36277879 http://dx.doi.org/10.1155/2022/9202128 |
_version_ | 1784813756894674944 |
---|---|
author | Cheng, Xin Han, Zhong-Xiao Su, Zi-Jie Zhang, Feng-Lin Li, Biao-Ping Jiang, Zhi-Rui Tang, Ling Yang, Jia-Shun |
author_facet | Cheng, Xin Han, Zhong-Xiao Su, Zi-Jie Zhang, Feng-Lin Li, Biao-Ping Jiang, Zhi-Rui Tang, Ling Yang, Jia-Shun |
author_sort | Cheng, Xin |
collection | PubMed |
description | Chronic liver disease(CLD) is a slow-developing and long-term disease that can cause serious damage to the liver. Thus far, it has been associated with viral hepatitis, non-alcoholic fatty liver disease(NAFLD), alcoholic liver disease(ALD), hepatic fibrosis(HF), liver cirrhosis (LC), and liver cancer. Qinghao Biejia Decoction (QBD) is a classic ancient Chinese herbal prescription with strong immune-enhancing, anti-inflammatory, and anti-tumor effects. In this study, we used a network pharmacology approach to investigate the molecular mechanisms of QBD in the inflammation-carcinoma transformation process of chronic liver disease. Two key drug targets, MAPK1 and PIK3CA, were screened using network pharmacology and molecular docking techniques, revealing dihydroartemisinin, artesunate, 12-O-Nicotinoylisolineolone, caffeic acid, and diincarvilone A as active ingredients involved in QBD mechanisms. The main signaling pathways involved were the PI3K-AKT signaling pathway and MAPK signaling pathway. In summary, our results indicated that QBD affects the inflammatory transformation of chronic liver disease through MAPK1 and PIK3CA and signaling pathways MAPK and PI3K/AKT. These data provide research direction for investigating the mechanisms underlying the inflammation-carcinoma transformation process in QBD for chronic liver disease. |
format | Online Article Text |
id | pubmed-9586778 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-95867782022-10-22 Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway Cheng, Xin Han, Zhong-Xiao Su, Zi-Jie Zhang, Feng-Lin Li, Biao-Ping Jiang, Zhi-Rui Tang, Ling Yang, Jia-Shun Biomed Res Int Research Article Chronic liver disease(CLD) is a slow-developing and long-term disease that can cause serious damage to the liver. Thus far, it has been associated with viral hepatitis, non-alcoholic fatty liver disease(NAFLD), alcoholic liver disease(ALD), hepatic fibrosis(HF), liver cirrhosis (LC), and liver cancer. Qinghao Biejia Decoction (QBD) is a classic ancient Chinese herbal prescription with strong immune-enhancing, anti-inflammatory, and anti-tumor effects. In this study, we used a network pharmacology approach to investigate the molecular mechanisms of QBD in the inflammation-carcinoma transformation process of chronic liver disease. Two key drug targets, MAPK1 and PIK3CA, were screened using network pharmacology and molecular docking techniques, revealing dihydroartemisinin, artesunate, 12-O-Nicotinoylisolineolone, caffeic acid, and diincarvilone A as active ingredients involved in QBD mechanisms. The main signaling pathways involved were the PI3K-AKT signaling pathway and MAPK signaling pathway. In summary, our results indicated that QBD affects the inflammatory transformation of chronic liver disease through MAPK1 and PIK3CA and signaling pathways MAPK and PI3K/AKT. These data provide research direction for investigating the mechanisms underlying the inflammation-carcinoma transformation process in QBD for chronic liver disease. Hindawi 2022-10-14 /pmc/articles/PMC9586778/ /pubmed/36277879 http://dx.doi.org/10.1155/2022/9202128 Text en Copyright © 2022 Xin Cheng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Cheng, Xin Han, Zhong-Xiao Su, Zi-Jie Zhang, Feng-Lin Li, Biao-Ping Jiang, Zhi-Rui Tang, Ling Yang, Jia-Shun Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title | Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title_full | Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title_fullStr | Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title_full_unstemmed | Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title_short | Network Pharmacology-Based Exploration on the Intervention of Qinghao Biejia Decoction on the Inflammation-Carcinoma Transformation Process of Chronic Liver Disease via MAPK and PI3k/AKT Pathway |
title_sort | network pharmacology-based exploration on the intervention of qinghao biejia decoction on the inflammation-carcinoma transformation process of chronic liver disease via mapk and pi3k/akt pathway |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586778/ https://www.ncbi.nlm.nih.gov/pubmed/36277879 http://dx.doi.org/10.1155/2022/9202128 |
work_keys_str_mv | AT chengxin networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT hanzhongxiao networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT suzijie networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT zhangfenglin networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT libiaoping networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT jiangzhirui networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT tangling networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway AT yangjiashun networkpharmacologybasedexplorationontheinterventionofqinghaobiejiadecoctionontheinflammationcarcinomatransformationprocessofchronicliverdiseaseviamapkandpi3kaktpathway |